Jayshree Chemicals (BSE 506520)₹6.07−5.75%Commodity Chemicals
In the Jun 2026 quarter (standalone), Jayshree Chemicals reported sales of ₹6.57 Cr, up 55.0% from Jun 2025, and net profit of ₹0.06 Cr. For the year to Mar 2026, sales were ₹20.94 Cr and net profit ₹0.30 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.63 | 3.29 | 3.40 | 3.69 | 3.80 | 4.58 | 4.17 | 4.24 | 4.89 | 5.69 | 6.13 | 6.57 |
| Expenses | 3.50 | 3.56 | 5.96 | 4.06 | 4.01 | 4.73 | 4.33 | 4.54 | 5.09 | 5.83 | 6.13 | 6.64 |
| Operating Profit | 0.10 | −0.28 | −2.57 | −0.38 | −0.22 | −0.16 | −0.17 | −0.31 | −0.21 | −0.16 | −0.01 | −0.08 |
| OPM % | 3.1% | −8.9% | −76.2% | −10.6% | −6.1% | −3.7% | −4.3% | −7.6% | −4.5% | −3.0% | −0.3% | −1.4% |
| Other Income | 0.25 | 0.19 | −0.80 | 0.31 | 0.39 | 0.07 | 0.04 | 0.32 | 0.34 | 0.24 | 0.24 | 0.21 |
| Interest | 0.00 | 0.01 | 0.04 | 0.03 | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Depreciation | 0.06 | 0.05 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.26 | −0.18 | −3.44 | −0.10 | 0.12 | −0.11 | −0.15 | −0.01 | 0.09 | 0.03 | 0.18 | 0.07 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Exceptional items | 0.00 | 0.00 | −1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.26 | −0.18 | −3.45 | −0.12 | 0.12 | −0.11 | −0.15 | −0.01 | 0.09 | 0.03 | 0.18 | 0.06 |
| EPS (Rs) | 0.08 | −0.05 | −1.17 | −0.03 | 0.03 | −0.03 | −0.04 | 0.00 | 0.02 | 0.00 | 0.05 | 0.01 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.33 | 0.96 | 4.77 | 6.88 | 1.79 | 0.55 | 6.73 | 8.96 | 12.83 | 16.92 | 20.94 | 23.28 |
| Expenses | 66.40 | 2.50 | 10.67 | 12.62 | 5.08 | 1.87 | 7.42 | 9.78 | 15.72 | 17.43 | 21.57 | 23.69 |
| Operating Profit | −13.36 | −1.55 | −5.92 | −5.76 | −3.30 | −1.33 | −0.71 | −0.85 | −2.94 | −0.57 | −0.70 | −0.46 |
| OPM % | −25.2% | −164.3% | −124.8% | −84.3% | −186.0% | −248.1% | −10.8% | −9.6% | −23.1% | −3.5% | −3.4% | −2.0% |
| Other Income | 57.15 | 2.57 | 7.43 | 1.63 | 2.71 | 1.45 | 0.72 | 1.02 | −0.21 | 0.64 | 1.11 | 1.03 |
| Interest | 19.94 | 0.02 | 0.16 | 0.16 | 0.02 | 0.00 | 0.00 | 0.02 | 0.11 | 0.07 | 0.08 | 0.10 |
| Depreciation | 4.22 | 0.30 | 0.31 | 0.29 | 0.27 | 0.25 | 0.25 | 0.24 | 0.24 | 0.25 | 0.00 | 0.00 |
| Profit before tax | 19.48 | 0.67 | 1.00 | −4.61 | −0.89 | −0.15 | −0.26 | −0.10 | −3.48 | −0.26 | 0.30 | 0.37 |
| Tax % | 0.3% | 0.0% | 176.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Exceptional items | 52.06 | 0.00 | 4.01 | 0.00 | 1.01 | 0.00 | −1.01 | 0.00 | −1.01 | 0.00 | 0.00 | 0.00 |
| Net Profit | 19.48 | 0.67 | −0.76 | −4.62 | −0.90 | −0.15 | −0.26 | −0.11 | −3.49 | −0.26 | 0.30 | 0.36 |
| EPS (Rs) | 6.62 | 0.22 | −0.25 | −1.57 | −0.30 | −0.04 | −0.08 | −0.03 | −1.18 | −0.08 | 0.10 | 0.08 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29.39 | 29.37 | 29.36 | 29.37 | 29.36 | 29.37 | 29.36 | 29.35 | 29.38 | 29.39 | 29.36 | 29.38 |
| Reserves | −23.04 | −3.53 | −2.78 | −6.97 | −11.60 | −12.50 | −12.67 | −13.00 | −13.12 | −18.92 | −19.20 | −18.89 |
| Borrowings | 141 | 0.00 | 0.00 | 1.11 | 0.16 | 0.07 | 0.00 | 0.00 | 0.00 | 0.57 | 0.79 | 0.56 |
| Other Liabilities | 35.69 | 14.12 | 13.00 | 9.98 | 9.37 | 7.16 | 7.08 | 7.09 | 7.02 | 6.73 | 7.18 | 6.67 |
| Total Liabilities | 183 | 39.96 | 39.58 | 33.49 | 27.29 | 24.10 | 23.77 | 23.44 | 23.28 | 17.77 | 18.13 | 17.72 |
| Fixed Assets | 145 | 4.85 | 4.54 | 4.30 | 3.98 | 3.68 | 3.44 | 3.19 | 2.92 | 2.61 | 2.73 | 0.03 |
| CWIP | 0.51 | 0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.59 | 0.60 | 0.76 | 3.28 | 2.40 | 0.82 | 7.17 | 0.64 | 0.64 | 0.00 | 1.02 | 0.10 |
| Other Assets | 37.48 | 34.51 | 34.22 | 25.91 | 20.91 | 19.60 | 13.16 | 19.61 | 19.72 | 15.16 | 14.38 | 17.59 |
| Inventories | 5.40 | 0.00 | 0.00 | 1.92 | 0.67 | 0.07 | 0.00 | 0.23 | 0.27 | 0.21 | 0.07 | 0.11 |
| Trade receivables | 14.91 | 0.64 | 1.12 | 3.76 | 3.18 | 1.96 | 1.38 | 2.81 | 3.89 | 3.77 | 4.51 | 5.04 |
| Cash & equivalents | 2.66 | 23.54 | 17.74 | 7.69 | 9.34 | 11.08 | 5.99 | 10.74 | 10.21 | 7.79 | 8.15 | 8.41 |
| Total Assets | 183 | 39.96 | 39.58 | 33.49 | 27.29 | 24.10 | 23.77 | 23.44 | 23.28 | 17.77 | 18.13 | 17.72 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 19.49 | 19.05 | 1.37 | −9.04 | −0.01 | −1.28 | −0.06 | −2.86 | −2.04 | −0.68 | −0.75 | −1.33 |
| Cash from investing activity | −0.81 | 138 | −3.58 | 7.34 | 3.04 | 3.98 | −5.28 | 6.70 | 0.73 | 1.31 | 0.49 | 1.56 |
| Cash from financing activity | −18.87 | −136 | −0.01 | −0.16 | −0.96 | −0.09 | 0.00 | 0.00 | 0.38 | −3.54 | 0.16 | −0.29 |
| Net cash flow | −0.18 | 20.91 | −2.24 | −1.90 | 2.05 | 2.59 | −5.35 | 3.83 | −0.91 | −2.90 | −0.08 | −0.06 |
| Capex | 1.85 | 0.07 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.41 | 0.02 |
| Free cash flow | 17.72 | 155 | 1.30 | −9.01 | 0.01 | −1.27 | −0.06 | 3.67 | −2.03 | −0.68 | −1.15 | −1.36 |
| CFO / OP % | −19,620.0% | −144.0% | −106.0% | 147.1% | −2.0% | 49.1% | 15.0% | 408.0% | 255.1% | 25.0% | 131.1% | 176.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 44 | 3 | 425 | 287 | 168 | 399 | 925 | 151 | 157 | 106 | 96 | 87 |
| Inventory days | 65 | 0 | — | 182 | 34 | 17 | 0 | 14 | 12 | 6 | 0 | 1 |
| Days payable | 172 | — | — | 211 | 86 | 150 | — | 25 | 20 | 5 | 5 | 4 |
| Cash conversion cycle | −61 | 4 | 426 | 259 | 118 | 268 | 926 | 143 | 151 | 109 | 93 | 86 |
| Working capital days | −358 | −23 | 1,275 | 536 | 97 | 241 | −69 | 88 | 93 | −4 | −42 | 33 |
| ROCE % | −4.4% | −13.9% | 4.5% | −18.8% | −21.1% | −10.8% | −0.7% | 1.5% | 1.9% | −15.1% | 0.2% | 2.2% |
For the Jun 2026 quarter, Jayshree Chemicals reported sales of ₹6.57 Cr, up 55.0% year on year and net profit of ₹0.06 Cr. The operating margin was −1.4%.
Jayshree Chemicals' sales for the year to Mar 2026 were ₹20.94 Cr; over the last twelve months they were ₹23.28 Cr.
Net profit for the year to Mar 2026 was ₹0.30 Cr, and ₹0.36 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.08.
Jayshree Chemicals reported borrowings of ₹0.56 Cr at Mar 2026, against cash and equivalents of ₹8.41 Cr.
Cash from operations was −₹1.33 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.36 Cr.